tumour microenvironment and signalling · mariano barbacid spanish national cancer research centre,...

1
www.embo-embl-symposia.org CONTACT [email protected] Kari Alitalo University of Helsinki, Finland Frances Balkwill Barts Cancer Institute, UK Mariano Barbacid Spanish National Cancer Research Centre, Spain Joanne Brugge Harvard Medical School, USA Vincenzo Cerundolo University of Oxford, UK Mike Clarke Stanford University, USA Maria Pia Cosma CRG Barcelona, Spain Karin de Visser Netherlands Cancer Institute, The Netherlands Mikala Egeblad Cold Spring Harbor Laboratory, USA Rudi Grosschedl MPI of Immunobiology and Epigenetics, Germany Lisa Johnson BC Cancer Agency, Canada Jos Jonkers Netherlands Cancer Institute, The Netherlands Chris Marshall The Institute of Cancer Research, UK Jan Paul Medema Academic Medical Center, The Netherlands Luis Parada UT Southwestern, USA Emmanuelle Passegué UCSF, USA Catrin Pritchard University of Leister, UK Andreas Trumpp Deutsches Krebsforschungszentrum, Germany David Tuveson Cancer Center Cold Spring Harbor, USA Terry van Dyke National Cancer Institute, USA Karen Vousden The Beatson Institute for Cancer Research, UK Zena Werb University of San Francisco, USA ORGANISERS Anton J. Berns Netherlands Cancer Institute, The Netherlands Pier Paolo Pandolfi Beth Israel Deaconess Medical Center/ Harvard Medical School, USA Barbara Pauly EMBO reports, Germany Additional speakers will be selected from abstracts. ABSTRACT SUBMISSION DEADLINE 13 FEBRUARY 2014 REGISTRATION DEADLINE 27 MARCH 2014 CONFIRMED SPEAKERS Tumour Microenvironment and Signalling EMBO | EMBL Symposium 7–10 May 2014 Heidelberg | Germany EMBL Advanced Training Centre YEARS I 1974–2014

Upload: others

Post on 07-Oct-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Tumour Microenvironment and Signalling · Mariano Barbacid Spanish National Cancer Research Centre, Spain Joanne Brugge Harvard Medical School, USA Vincenzo Cerundolo University of

www.embo-embl-symposia.org CONTACT

[email protected]

Kari AlitaloUniversity of Helsinki, Finland

Frances BalkwillBarts Cancer Institute, UK

Mariano BarbacidSpanish National Cancer Research

Centre, Spain

Joanne BruggeHarvard Medical School, USA

Vincenzo CerundoloUniversity of Oxford, UK

Mike ClarkeStanford University, USA

Maria Pia CosmaCRG Barcelona, Spain

Karin de VisserNetherlands Cancer Institute,

The Netherlands

Mikala EgebladCold Spring Harbor Laboratory, USA

Rudi GrosschedlMPI of Immunobiology and

Epigenetics, Germany

Lisa JohnsonBC Cancer Agency, Canada

Jos JonkersNetherlands Cancer Institute,

The Netherlands

Chris MarshallThe Institute of Cancer Research,

UK

Jan Paul MedemaAcademic Medical Center,

The Netherlands

Luis ParadaUT Southwestern, USA

Emmanuelle PasseguéUCSF, USA

Catrin PritchardUniversity of Leister, UK

Andreas TrumppDeutsches Krebsforschungszentrum,

Germany

David TuvesonCancer Center Cold Spring Harbor,

USA

Terry van DykeNational Cancer Institute, USA

Karen VousdenThe Beatson Institute for Cancer

Research, UK

Zena WerbUniversity of San Francisco, USA

ORGANISERS

Anton J. BernsNetherlands Cancer Institute, The Netherlands

Pier Paolo PandolfiBeth Israel Deaconess Medical Center/ Harvard Medical School, USA

Barbara PaulyEMBO reports, Germany

Additional speakers will be selected from abstracts.

ABSTRACT SUBMISSIONDEADLINE

13 FEBRUARY 2014

REGISTRATION DEADLINE

27 MARCH 2014

CONFIRMED SPEAKERS

TumourMicroenvironment

and Signalling

EMBO | EMBLSymposium

7–10 May 2014Heidelberg | GermanyEMBL Advanced Training Centre

YEARS I 1974–2014